Consolidated Balance Sheets (Unaudited) - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 4,005,477	$ 2,977,713
Marketable securities	1,000,000	2,976,573
Accounts receivable, net of allowance for credit losses of $10,000, respectively	661,838	312,664
Prepaid expenses and other current assets	863,589	517,785
Inventories	2,860,029	2,638,186
Advances on contracts	1,421,120	1,371,548
Total current assets	10,812,053	10,794,469
Furniture, fixtures and equipment, net	8,023	10,024
Intangibles, net	168,956	178,636
Right of use assets finance lease	6,835	8,998
Right of use assets operating lease	330,769	355,235
Other assets	24,150	24,150
Total assets	11,350,786	11,371,512
Current liabilities:
Accrued expenses and other payables	1,241,403	1,511,717
Accrued expenses, related party	170,720	137,189
Accrued Liabilities noncontrolling interest	214,000	214,000
Current portion of finance lease liabilities	8,219	10,264
Current portion of operating lease liabilities	107,355	103,427
Total current liabilities	3,636,603	3,076,713
Non-current portion of finance lease liabilities	0	434
Non-current portion of operating lease liabilities	253,774	281,853
Total liabilities	3,890,377	3,359,000
Commitments
Stockholders’ equity
Common stock, par value $0.001; authorized 100,000,000 shares; 76,632,279 shares issued and 76,598,946 shares outstanding as of March 31, 2024 shares; 75,881,840 shares issued and 75,848,507 shares outstanding as of December 31, 2023;	76,632	75,881
Additional paid in capital	133,075,331	132,187,656
Accumulated deficit	(124,780,038)	(123,339,509)
Treasury stock, at cost, 33,333 shares	(911,516)	(911,516)
Total Milestone Scientific, Inc. stockholders' equity	7,460,409	8,012,512
Total liabilities and stockholders’ equity	11,350,786	11,371,512
Nonrelated Party [Member]
Current liabilities:
Accounts payable	1,105,589	689,604
Related Party [Member]
Current liabilities:
Accounts payable	$ 789,317	$ 410,512